Skip to content

BBNX BBNX Proceeds From Issuance Of Convertible Preferred Stock

Proceeds From Issuance Of Convertible Preferred Stock at other companies

KKR & Co. logo
KKR & Co.KKR
$0-100%
Lexicon Pharmaceuticals logo
Lexicon PharmaceuticalsLXRX
$26.55M
QuantumScape Corporation
 logo
QuantumScape Corporation QS
$44.12M
Maze Therapeutics, Inc. Common Stock logo
Maze Therapeutics, Inc. Common StockMAZE
$17.7M
Evolution Metals & Technologies Corp.
 logo
Evolution Metals & Technologies Corp. EMAT
$5.55M
Evommune
 logo
Evommune EVMN
$2M

Other financials

Income statement

See full
Revenue$27.6M+56.6%
Gross profit$16.4M+83.2%
Operating income-$24.3M-30.2%
Net income-$21.9M+23.6%
EPS (diluted)-$0.49+47.3%

Balance sheet

See full
Cash & equivalents$30.2M-28.9%
Total debt$6.9M-0.9%
Total equity$271.2M-13.5%
Total assets$304.4M-9.9%

Cash flow

See full
Operating cash flow-$23.8M-19.3%
CapEx$1.4M+314%
Free cash flow-$25.2M-24.1%

Valuation

See full
Market cap$708.98M-8.6%
Enterprise value$685.68M
P/S6.4×

Profitability

See full
Gross margin57.2%+3.2pp
Operating margin-70.1%-6.4pp
Net margin-60.3%-17.4pp
FCF margin-55.4%-14.3pp

Returns & leverage

See full
Return on equity-22.7%
Debt / equity0.0×
Current ratio10.7×-5.2×

Where this comes from

Reported directly by BBNX in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock.

The official record: BBNX’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about BBNX's proceeds from issuance of convertible preferred stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BBNX's proceeds from issuance of convertible preferred stock?
BBNX (BBNX) reported proceeds from issuance of convertible preferred stock of $14.92M in Q4 2024.
How has BBNX's proceeds from issuance of convertible preferred stock changed year-over-year?
BBNX's proceeds from issuance of convertible preferred stock decreased by 40.9% year-over-year, from $25.25M to $14.92M.